An alternative POLDIP3 transcript promotes hepatocellular carcinoma progression.

[1]  R. Sivaperumal,et al.  Protective effects of dieckol on N-nitrosodiethylamine induced hepatocarcinogenesis in rats. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  P. Maturu,et al.  Modulatory role of Pterocarpus santalinus against alcohol-induced liver oxidative/nitrosative damage in rats. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  Tengteng Zhu,et al.  Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3 , 2016, The FEBS journal.

[4]  Jung-Hwan Yoon,et al.  Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  T. Tilli,et al.  Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells , 2016, Tumor Biology.

[6]  Marietta Y. W. T. Lee,et al.  PDIP46 (DNA polymerase δ interacting protein 46) is an activating factor for human DNA polymerase δ , 2016, Oncotarget.

[7]  K. Hashem,et al.  Cerium oxide nanoparticles alleviate oxidative stress and decreases Nrf-2/HO-1 in D-GALN/LPS induced hepatotoxicity. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  D. Rio,et al.  Mechanisms and Regulation of Alternative Pre-mRNA Splicing. , 2015, Annual review of biochemistry.

[9]  K. Palm,et al.  Diagnostic significance of alternative splice variants of REST and DOPEY1 in the peripheral blood of patients with breast cancer , 2015, Tumor Biology.

[10]  Jessica Zucman-Rossi,et al.  Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets , 2015, Nature Genetics.

[11]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[12]  E. Borazan,et al.  Differential expression of the UGT1A family of genes in stomach cancer tissues , 2015, Tumor Biology.

[13]  D. Bates,et al.  Hallmarks of alternative splicing in cancer , 2014, Oncogene.

[14]  Dan Chen,et al.  The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression. , 2014, Cancer cell.

[15]  Dino Amadori,et al.  ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signaling , 2014, Nature Cell Biology.

[16]  Jing Fang,et al.  BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells , 2014, Nature Communications.

[17]  Jignesh R. Parikh,et al.  Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. , 2014, Cell stem cell.

[18]  Shuhan Sun,et al.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.

[19]  Jian Zhang,et al.  Misregulation of pre-mRNA alternative splicing in cancer. , 2013, Cancer discovery.

[20]  M. Alló,et al.  Alternative splicing: a pivotal step between eukaryotic transcription and translation , 2013, Nature Reviews Molecular Cell Biology.

[21]  C. Chenu,et al.  Mammalian Sulf1 RNA alternative splicing and its significance to tumour growth regulation , 2012, Tumor Biology.

[22]  Fang Wang,et al.  The histone deacetylase 4/SP1/microrna‐200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma , 2011, Hepatology.

[23]  A. Zell,et al.  TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR , 2011, Nucleic acids research.

[24]  D. Sahani,et al.  HCC and angiogenesis: possible targets and future directions , 2011, Nature Reviews Clinical Oncology.

[25]  Lewis R. Roberts,et al.  Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.

[26]  Shuhan Sun,et al.  miR‐17‐5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen‐activated protein kinase‐heat shock protein 27 pathway , 2010, Hepatology.

[27]  J. Blenis,et al.  SKAR Links Pre-mRNA Splicing to mTOR/S6K1-Mediated Enhanced Translation Efficiency of Spliced mRNAs , 2008, Cell.

[28]  S. Cory,et al.  The Bcl-2 apoptotic switch in cancer development and therapy , 2007, Oncogene.

[29]  S. Thorgeirsson,et al.  A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells , 2006, Nature Medicine.

[30]  S. Gygi,et al.  SKAR Is a Specific Target of S6 Kinase 1 in Cell Growth Control , 2004, Current Biology.

[31]  G. Bonser,et al.  Preventable Cancer , 1912, The Indian Medical Gazette.

[32]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.